Portfolio company
KAI Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops and manufactures biologic medicines for patients with cardiovascular, metabolic, inflammatory, oncological and rare diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kailera
This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.
j2hbio
This company develops small molecule pharmaceuticals and provides contract manufacturing services to global pharmaceutical partners to treat rare and incurable diseases.
Amgen
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Bial
This company develops and manufactures pharmaceutical medicines for patients with neurological, cardiovascular and respiratory conditions.
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
Corus Pharmaceuticals
This company develops biopharmaceutical medicines to treat patients with HIV, viral hepatitis, cancer and inflammatory diseases.
Edgewise
This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.
